Bringing together leading experts regarding kidney disease research and patient care, Field Notes is an engaging forum discussing the latest developments, innovations, and trends that seek to improve outcomes and quality of life for individuals living with chronic disease. Fresenius Medical Care North America is the premiere healthcare company focused on providing innovative products and the highest quality care to people with renal and other conditions.

 

Your Feedback is Welcome!


Get in touch to offer comments, topics of interest to you, or potential speakers.

LET US KNOW


 

Published: March 2021

Last year in the U.S., home dialysis reached 14% of all treatments by Fresenius Kidney Care, and home hemodialysis with the NxStage system grew at an incredible 37%. Joe Turk, former president of NxStage Medical and current president of home and critical care therapies for Fresenius Medical Care North America, provides an inside look at how FMCNA’s merger with NxStage Medical is helping evolve and grow technology for home dialysis and critical care.

Published: March 2021

Originally developed to treat diabetes, SGLT2 inhibitors are potentially groundbreaking in slowing the progression of chronic kidney disease (CKD). Dr. Robert Kossmann, Executive Vice President, Global Head of Renal Therapies, and Chief Medical Officer of Fresenius Medical Care North America joins Field Notes to examine how this class of drug can be used to intervene earlier with patients and is a key tool within value-based care.

Published: February 2021

When kidneys do not work, a cycle of damaging health events is started that can ultimately lead to significant bone damage for patients. Dr. Michael Anger, Chief Medical Officer of the Renal Therapies Group, joins Field Notes to discuss the methods used to prevent bone damage, preventing the need for additional and expensive therapies for patients. 

Published: February 2021

Nephrology has been under-represented in clinical research, even as we have witnessed rapid progress in precision medicine in other specialty areas. A new initiative to build the world’s largest renal-focused genomic registry by Frenova, the clinical research division of Fresenius Medical Care, aims to change that. Dr. Frank Maddux, Global Chief Medical Officer, joins Field Notes to explain how this groundbreaking registry will impact the future of kidney care for years to come. 

Published: January 2021

While the distribution of COVID-19 vaccines continues across the country, the FDA has also recently granted Emergency Use Authorizations (EUA) for new monoclonal antibody therapies specifically for COVID-19 patients living with chronic kidney disease. Chance Mysayphonh, PharmD, clinical pharmacist for Fresenius Medical Care North America, joins Field Notes to discuss how these exciting new therapies will be used in Fresenius Kidney Care centers.

Published: January 2021

Throughout the COVID-19 pandemic, the work of dialysis nurses and technicians working inside hospitals and other major care facilities has been critical as a significant percentage of COVID-19 patients battle acute kidney injury. Gina Sharkey and Tana Waack, both registered nurses who work closely together as Vice Presidents of Inpatient Services at FMCNA, join Field Notes to provide a behind-the-scenes look at the front-lines inside some of the hospitals hit hardest by COVID-19.

Published: December 2020

With both Moderna and Pfizer-BioNTech distributing their COVID-19 vaccines across the country to battle the ongoing pandemic, Phaneth Keo, Pharm.D., Vice President of the Medical Strategies for Innovative Therapies at FMCNA’s Renal Therapies Group, joins Field Notes to discuss the science and process behind the groundbreaking emergency use authorizations by the FDA.

Published: December 2020

With the ability to provide patients greater control over their own treatment and improve their quality of life, home dialysis is a core component of the care model at Fresenius Medical Care North America. Even the federal government is pushing to see more patients treated at home. Dr. Michael Kraus, Associate Chief Medical Officer of Fresenius Kidney Care, joins Field Notes to break down the benefits of home treatment and provide insight into the company’s strategy and approach.

Published: November 2020

Health care providers throughout the world are working together to share key clinical information to improve patient quality, safety and efficiency of healthcare. Dr. Emel Hamilton joins Field Notes to share the details of how FMCNA is leading the way in improving care transitions for chronic kidney disease patients.

Published: October 2020

How has one of the largest, leading healthcare companies in the United States responded to the COVID-19 pandemic? Dr. Jeffrey Hymes joins Field Notes to discuss how the company’s efforts to prepare for a global pandemic enabled Fresenius Medical Care North America to stay ahead of the curve and keep its patients safe. 

Published: October 2020

Transitional Care Units help people recently diagnosed with kidney failure learn about the treatment options available to them including home dialysis. Dr. Dinesh Chatoth, Associate Chief Medical Officer of Fresenius Kidney Care, discusses the importance of comprehensive, hands-on education that is individualized for each patient, empowering them to manage their own care.

Published: September 2020

Dr. Ben Hippen, advisor to the Fresenius Medical Care Foundation and partner at Metrolina Nephrology Associates, discusses the importance of improving the organ transplant process for patients facing kidney failure and the health care industry in general.

Published: September 2020

Dr. Laura Niklason, co-founder of Humacyte, joins Field Notes to discuss the exciting potential of her company’s human acellular vessel, which could transform vascular access for dialysis patients.  

Published: September 2020

With hurricane season upon us, Bob Loeper, Vice President of Disaster Response for Fresenius Medical Care North America, joins Field Notes to discuss what it takes to ensure dialysis care for patients even after a major event when roads are blocked, and major utilities are down.

Published: August 2020

Dr. Peter Kotanko discusses a new mathematical model suggesting that pool testing is a more accurate and efficient method to map the spread of COVID-19 in certain communities.  

Headshot of Dr. Ted Toffelmire

Published: August 2020

As the COVID-19 pandemic continues, its impacts on the body continue to be understood. Dr. Ted Toffelmire, the Senior Director of Medical Affairs in Canada for Fresenius Medical Care North America, joins Field Notes to discuss a potential link between the devastating virus and acute kidney injury.

Headshot of Len Usvyat, PhD

Published: July 2020

Len Usvyat, PhD, Vice President of Applied Advanced Analytics, joins Field Notes to explain how artificial intelligence is being used to provide better treatment for people with kidney disease by predicting potential outcomes and future health care needs.

Headshot of Dr. Dugan Maddux

Published: July 2020

Dr. Dugan Maddux, Vice President of Kidney Disease Initiatives for Fresenius Medical Care North America, joins Field Notes to discuss the consequences of food insecurity for people living with serious chronic conditions and the importance of medically tailored meals in treating kidney disease. 

Headshot of Dr. Ahmad Sharif

Published: June 2020

Dr. Ahmad Sharif, Senior Vice President and Chief Medical Information Officer at Fresenius Medical Care North America, discusses the important use of telehealth to safely treat patients during the COVID-19 era and what the future holds for virtual patient care when the pandemic ends. 

Headshot of Felicia Speed

Published: May 2020

In this episode, we talk to Felicia Speed, LMSW, Corporate Director of Social Work Services at Fresenius Medical Care North America, about Physician Burnout: the emotional and mental strain that comes with providing care in a time of crisis. 

Google Play and the Google Play logo are trademarks of Google LLC.
The Apple logo and Apple Podcasts are trademarks of Apple Inc., registered in the U.S. and other countries.